TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors
- 1 March 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (3) , 397-404
- https://doi.org/10.1016/0277-5379(90)90241-k
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumoursEuropean Journal of Cancer and Clinical Oncology, 1984
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Determination of tamoxifen and metabolites in human serum by high-performance liquid chromatography with post-column fluorescence activationJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patientsInternational Journal of Cancer, 1981
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma modelPublished by Elsevier ,1980
- Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal WomenJournal of Clinical Investigation, 1979
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- Hormonal Therapy of Breast Cancer: New Approaches and ConceptsAnnals of Internal Medicine, 1978
- EFFECT OF THE ANTI-OESTROGEN TAMOXIFEN ON PLASMA LEVELS OF LUTEINIZING HORMONE, FOLLICLE-STIMULATING HORMONE, PROLACTIN, OESTRADIOL AND PROGESTERONE IN NORMAL PRE-MENOPAUSAL WOMENJournal of Endocrinology, 1976